Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Maga

Showing results (71-80 of 214) with videos related to

Pageof 22
Sort By:
Nucleic Acids Research|March 15, 2014
Mutational analysis of the HIV-1 auxiliary protein Vif identifies independent domains important for the physical and functional interaction with HIV-1 reverse transcriptaseAlexandra Kataropoulou, Chiara Bovolenta, Amalia Belfiore, et al.
Journal of Chemical Information and Modeling|November 7, 2015
Homology Model-Based Virtual Screening for the Identification of Human Helicase DDX3 InhibitorsRoberta Fazi, Cristina Tintori, Annalaura Brai, et al.
The Plant Cell|February 18, 2011
Oxidative DNA damage bypass in Arabidopsis thaliana requires DNA polymerase λ and proliferating cell nuclear antigen 2Alessandra Amoroso, Lorenzo Concia, Caterina Maggio, et al.
Bioorganic & Medicinal Chemistry Letters|January 31, 2009
Indolyl-pyrrolone as a new scaffold for Pim1 inhibitorsStefania Olla, Fabrizio Manetti, Emmanuele Crespan, et al.
Journal of Chemical Information and Modeling|February 6, 2007
Structure-based pharmacophore identification of new chemical scaffolds as non-nucleoside reverse transcriptase inhibitorsMaria Letizia Barreca, Laura De Luca, Nunzio Iraci, et al.
Nucleic Acids Research|April 17, 2009
Mutational analysis of the HIV-1 auxiliary protein Vif identifies independent domains important for the physical and functional interaction with HIV-1 reverse transcriptaseAlexandra Kataropoulou, Chiara Bovolenta, Amalia Belfiore, et al.
Expert Opinion on Drug Discovery|November 22, 2012
New in silico and conventional in vitro approaches to advance HIV drug discovery and designGiovanni Maga, Nevena Veljkovic, Emmanuele Crespan, et al.
Antiviral Chemistry & Chemotherapy|November 19, 2011
Mechanism of interaction of novel indolylarylsulfone derivatives with K103N and Y181I mutant HIV-1 reverse transcriptase in complex with its substratesAlberta Samuele, Sara Bisi, Alexandra Kataropoulou, et al.
Antiviral Research|November 6, 2008
Non-nucleoside HIV-1 reverse transcriptase inhibitors di-halo-indolyl aryl sulfones achieve tight binding to drug-resistant mutants by targeting the enzyme-substrate complexAlberta Samuele, Alexandra Kataropoulou, Marco Viola, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 6, 2013
DNA polymerase δ-interacting protein 2 is a processivity factor for DNA polymerase λ during 8-oxo-7,8-dihydroguanine bypassGiovanni Maga, Emmanuele Crespan, Enni Markkanen, et al.
Pageof 22

Showing results (71-80 of 214) with videos related to

Sort By:
Pageof 22
Nucleic Acids Research|March 15, 2014
Mutational analysis of the HIV-1 auxiliary protein Vif identifies independent domains important for the physical and functional interaction with HIV-1 reverse transcriptaseAlexandra Kataropoulou, Chiara Bovolenta, Amalia Belfiore, et al.
Journal of Chemical Information and Modeling|November 7, 2015
Homology Model-Based Virtual Screening for the Identification of Human Helicase DDX3 InhibitorsRoberta Fazi, Cristina Tintori, Annalaura Brai, et al.
The Plant Cell|February 18, 2011
Oxidative DNA damage bypass in Arabidopsis thaliana requires DNA polymerase λ and proliferating cell nuclear antigen 2Alessandra Amoroso, Lorenzo Concia, Caterina Maggio, et al.
Bioorganic & Medicinal Chemistry Letters|January 31, 2009
Indolyl-pyrrolone as a new scaffold for Pim1 inhibitorsStefania Olla, Fabrizio Manetti, Emmanuele Crespan, et al.
Journal of Chemical Information and Modeling|February 6, 2007
Structure-based pharmacophore identification of new chemical scaffolds as non-nucleoside reverse transcriptase inhibitorsMaria Letizia Barreca, Laura De Luca, Nunzio Iraci, et al.
Nucleic Acids Research|April 17, 2009
Mutational analysis of the HIV-1 auxiliary protein Vif identifies independent domains important for the physical and functional interaction with HIV-1 reverse transcriptaseAlexandra Kataropoulou, Chiara Bovolenta, Amalia Belfiore, et al.
Expert Opinion on Drug Discovery|November 22, 2012
New in silico and conventional in vitro approaches to advance HIV drug discovery and designGiovanni Maga, Nevena Veljkovic, Emmanuele Crespan, et al.
Antiviral Chemistry & Chemotherapy|November 19, 2011
Mechanism of interaction of novel indolylarylsulfone derivatives with K103N and Y181I mutant HIV-1 reverse transcriptase in complex with its substratesAlberta Samuele, Sara Bisi, Alexandra Kataropoulou, et al.
Antiviral Research|November 6, 2008
Non-nucleoside HIV-1 reverse transcriptase inhibitors di-halo-indolyl aryl sulfones achieve tight binding to drug-resistant mutants by targeting the enzyme-substrate complexAlberta Samuele, Alexandra Kataropoulou, Marco Viola, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 6, 2013
DNA polymerase δ-interacting protein 2 is a processivity factor for DNA polymerase λ during 8-oxo-7,8-dihydroguanine bypassGiovanni Maga, Emmanuele Crespan, Enni Markkanen, et al.
Pageof 22